A fused weighted federated learning-based adaptive approach for early-stage drug prediction

一种基于融合加权联邦学习的自适应早期药物预测方法

阅读:1

Abstract

Early accurate drug prediction is crucial in clinical decision support, where privacy of the patient data is a paramount importance. In this study, we introduce a fused weighted adaptive federated learning (FWAFL) framework to achieve joint training among distributed healthcare institutions without requiring raw data sharing. The method employs local model updates and client-level adaptive weighting to enhance generalization and performance while preserving data privacy. A multilayer perceptron is fitted on tabular drug datasets in a decentralized manner, and an ensemble model is created by weighted averaging of the fitted local parameters. Validation results show that our approach outperforms the baseline federated and centralized approaches in both accuracy and robustness. The proposed approach demonstrates its promise for ensuring secure and privacy-preserving early drug prediction in real healthcare environments. An adaptive Federated Learning-based drug prediction approach is used to identify treatment early in the healthcare industry. The proposed model achieves an accuracy of 0.927 and a miss rate of 0.073, which is more accurate than the previously proposed approaches.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。